1433 / 1851
Risk of Secondary breast cancer (from GHSG trial)
5804 early stage HL patients (GHSG trial HD7-HD8-HD10-HD11-HD14)
Median age: 34 years
Female patients: 48%
100 HL
patients
48
females
males
22
Age ≤30
Age > 30
RT volume
not involving
breasts
15
received
RT dose to
the breasts
RT-induced
Breast Cancers at 30 years:
2-3 cases
(15-20%)